Lilly – Finance News Today

Eli Lilly LLY cuts 2024 revenue outlook on weight loss drugs

Eli Lilly weight loss drug Zepbound no longer in shortage

Novo and Lilly contender Zealand Pharma targets ‘next generation’ of

Eli Lilly releases new, cheaper form of weight loss drug

Eli Lilly weight loss drug cuts risk of developing diabetes in trial

Here’s why Eli Lilly is down heading into earnings — and how to play it

Deutsche Bank says Eli Lilly stock is a buy, in line with our rating

Eli Lilly (LLY) earnings Q2 2024

Eli Lilly Zepbound, Mounjaro available after shortages, FDA says

Novo Nordisk, Eli Lilly shares slide on Roche’s obesity drug trial